News und Analysen
HBM Healthcare Investments publishes net asset value per share of CHF 254.80 as at 31 March 2023
HBM Healthcare Investments publishes net asset value per share of CHF 254.80 as at 31 March 2023
HBM Healthcare Investments announces the return of Dr Andreas Wicki; new investment of USD 12 million in ArriVent Biopharma
HBM Healthcare Investments announces the return of Dr Andreas Wicki; new investment of USD 12 million in ArriVent Biopharma
Annual General Meeting of Bellevue Group AG – all proposals approved
Annual General Meeting of Bellevue Group AG – all proposals approved
Partners Group reports continued management fee growth; performance fees in line with guidance; dividend up 12% to CHF 37.00 per share
Partners Group reports continued management fee growth; performance fees in line with guidance; dividend up 12% to CHF 37.00 per share
Cembra publishes agenda items for the Annual General Meeting 2023 and its Annual Report 2022
Cembra publishes agenda items for the Annual General Meeting 2023 and its Annual Report 2022
CREALOGIX achieved a positive operating result in the first half of 2022/2023, further measures to strengthen profitability in implementation
CREALOGIX achieved a positive operating result in the first half of 2022/2023, further measures to strengthen profitability in implementation
Partners Group announces amendments to the composition of its Board of Directors and an addition to its Executive Team
Partners Group announces amendments to the composition of its Board of Directors and an addition to its Executive Team
Bellevue reports market-driven decline in net profit to CHF 25.3 mn – dividend proposal underscores the solid business model and confidence
Bellevue reports market-driven decline in net profit to CHF 25.3 mn – dividend proposal underscores the solid business model and confidence
Cembra reports strong full-year results, with net income up 5%
Cembra reports strong full-year results, with net income up 5%
Changes in the Board of Directors of Bellevue Group
Changes in the Board of Directors of Bellevue Group
Successful IPO of HBM portfolio company Mineralys Therapeutics
Successful IPO of HBM portfolio company Mineralys Therapeutics
HBM Healthcare Investments informs about a temporary change in the Executive Board
HBM Healthcare Investments informs about a temporary change in the Executive Board
Bellevue expects significantly lower net profit of CHF 25 mn – Dividend of CHF 2.00 per share proposed
Bellevue expects significantly lower net profit of CHF 25 mn – Dividend of CHF 2.00 per share proposed
Partners Group continues to strengthen its presence in Japan with the appointment of Teppei Kawai as Country Head
Partners Group continues to strengthen its presence in Japan with the appointment of Teppei Kawai as Country Head
Preliminary information on the 2022/2023 half-year statement: CREALOGIX achieves turnaround with positive operating result
Preliminary information on the 2022/2023 half-year statement:
CREALOGIX achieves turnaround with positive operating result
HBM Healthcare Investments publishes Quarterly Report with key figures for the quarter ended 31 December 2022 and for the first nine months of the 2022/2023 financial year
HBM Healthcare Investments publishes Quarterly Report with key figures for the quarter ended 31 December 2022 and for the first nine months of the 2022/2023 financial year
Bellevue Asset Management launches debut private equity secondaries fund
Bellevue Asset Management launches debut private equity secondaries fund
Partners Group reports 2022 fundraising within guidance; communicates expected range of USD 17 to 22 billion for 2023
Partners Group reports 2022 fundraising within guidance; communicates expected range of USD 17 to 22 billion for 2023
Partners Group acquires SureWerx, a leading North American supplier of personal protective equipment, safety gear, and tool solutions
Partners Group acquires SureWerx, a leading North American supplier of personal protective equipment, safety gear, and tool solutions